Johannes Husing

Bochum, NW 44801, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Multiple imputation for missing values in ordinal variables from cancer registry data when performing Cox proportional hazards regression.

Multiple imputation for missing values in ordinal variables from cancer registry data when performing Cox proportional hazards regression.

Journal: BMC medical research methodology

Published: October 30, 2025

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.

Journal: European urology

Published: January 23, 2025

PSMA-PET research: addressing challenges and prospects - Authors' reply.

PSMA-PET research: addressing challenges and prospects - Authors' reply.

Journal: The Lancet. Oncology

Published: October 04, 2024

Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, Germany.

Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, Germany.

Journal: BMC urology

Published: June 09, 2024

Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.

Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.

Journal: The Lancet. Oncology

Published: April 23, 2024

Incidence and Survival of Patients With Prostate Cancer in North-Rhine Westphalia, Germany.

Incidence and Survival of Patients With Prostate Cancer in North-Rhine Westphalia, Germany.

Journal: Clinical genitourinary cancer

Published: April 02, 2024

Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial.

Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: July 29, 2023

Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial.

Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial.

Journal: International journal of radiation oncology, biology, physics

Published: February 22, 2023

Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial.

Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 30, 2021

Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).

Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).

Journal: International journal of radiation oncology, biology, physics

Published: October 10, 2020

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial.

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial.

Journal: BMJ open

Published: October 01, 2020

Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Journal: NPJ vaccines

Published: September 23, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026